Shou-Liang Gong

Shou-Liang Gong

Auto-generated profile, based on publicly available information

Shou-Liang Gong

Department of Radiation Oncology, The First Bethune Hospital of Jilin University, Changchun, Jilin, 130021, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
TXTiankai Xu
Tiankai Xu
YZYuyu Zhang
Yuyu Zhang
PCPengyu Chang
Pengyu Chang
SGShouliang Gong
Shouliang Gong
LSLihong Shao
Lihong Shao
LDLihua Dong
Lihua Dong
Since radiotherapy is widely used in managing thoracic tumors, physicians have begun to realize that radiation-induced lung injury (RILI) seriously limits the effects of radiotherapy. Unfortunately, there are still no effective methods for controlling RILI. Over the last few decades numerous studies have reported the beneficial effects of mesenchymal stem cells (MSCs) on tissue repair and regeneration. MSCs can not only differentiate into lung alveolar epithelial cells and secrete anti-inflammatory factors, but they also deliver some vehicles for gene therapy in repairing the injured lung, which provides new ideas for managing RILI. Thus, many scientists have attempted to manage RILI using MSC-based therapy. However, as a novel therapy MSCs still face various limitations. Herein, we shed light on the current understanding of MSC-based therapy for RILI, including the feasibility, molecular mechanisms, animal studies, and clinical research of MSC-based therapy for RILI. We also present an overview of RILI and MSCs.

31 December 2010 in Biomedical and Environmental Sciences
Verified
Journal Article
Closed access
GCGuang-Hui Cheng
Guang-Hui Cheng
NWNing Wu
Ning Wu
DJDe-Fu Jiang
De-Fu Jiang
HZHong-Guang Zhao
Hong-Guang Zhao
QZQian Zhang
Qian Zhang
SGShou-Liang Gong
Shou-Liang Gong

1 August 2013 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
ZWZhi-Cheng Wang
Zhi-Cheng Wang
JWJian-Feng Wang
Jian-Feng Wang
YLYan-Bo Li
Yan-Bo Li
CGCai-Xia Guo
Cai-Xia Guo
YLYang Liu
Yang Liu
SGShou-Liang Gong
Shou-Liang Gong

1 January 2004 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SGShou-Liang Gong
Shou-Liang Gong
GGGang Zhao Shou-Liang Gong
Gang Zhao Shou-Liang Gong
GLGuang-Wei Liu
Guang-Wei Liu
AIM: To explore the ability of recombinant toxin luteinizing hormone releasing hormone-Pseudomonas aeruginosa exotoxin 40 (LHRH-PE40) and LHRH binding to LHRH receptor (LHRHR) on the membrane surface of human liver cancer HEPG cells. METHODS: LHRH was labeled by using 125I with enzymatic reaction. The affinity and receptor volume of LHRH-PE40 and LHRH binding to LHRHR on the membrane surface of human liver cancer cells were measured with radioligand receptor assay. RESULTS: The specific activity of LHRH labeled with 125I was 2.7 × 104 kBq/μL, and its radiochemical purity reached to 99.2%-99.7%. The binding of 125I to LHRH was maximal for 240 min in the warm cultivation, and this binding was stabilized. The inhibiting rates of 125I-LHRH and LHRH on the proliferation of human liver cancer HEPG cells were not significantly different. On the basis of the saturation curve of 125I-LHRH binding to the membrane LHRHR of HEPG cells, 125I-LHRH of 1 × 105 cpm was selected for radioligand receptor assay. The affinity constants (Kd) of LHRH-PE40 and LHRH binding to the membrane LHRHR of HEPG cells were 0.43 ± 0.12 nmol/L and 4.86 ± 1.47 nmol/L, respectively, and their receptor volumes were 0.37 ± 0.15 μmol/g and 0.42 ± 0.13 μmol/g, respectively. The binding of LHRH-PE40 to the membrane protein of normal liver cells was not observed. CONCLUSION: The recombinant toxin LHRH-PE40 binding to the membrane surface of LHRHR of human liver cancer HEPG cells was very strong, while the specific binding of it to normal liver cells was not observed. The results provide an important experimental basis for the clinical application of LHRH-PE.

29 May 2008 in Frontiers of Medicine in China
Verified
Journal Article
Closed access
PDF file
XDXiang Du
Xiang Du
HZHongguang Zhao
Hongguang Zhao
WWWen Wang
Wen Wang
WGWei Guo
Wei Guo
SGShouliang Gong
Shouliang Gong